The Effect of Insulin Administration on Medication Adherence in Type 2 Diabetes Mellitus Patients with Neurological Complications
Downloads
Background: Medication adherence is essential to achieving controlled blood sugar in diabetic patients. Insulin generally provides better glycemic control but is considered painful and requires special techniques. Insulin administration in patients with neurological complications requires particular consideration because these complications can cause physical and cognitive barriers. Objective: This study analyses the effect of insulin administration on medication adherence in diabetic patients with neurological complications and the influence of various confounding variables (baseline characteristics, medical and medication history). Methods: This observational study was conducted with a cross-sectional design at a government hospital in East Jakarta from September 2021 to January 2022. The sample was type 2 diabetes mellitus patients with neurological complications who received antidiabetics for at least six months. The neurological complications include central nervous disorders (such as stroke) and peripheral nervous disorders (such as neuropathy). The independent variable was insulin administration, while the dependent variable was adherence, measured using subjective methods [Adherence to Refills and Medications Scale (ARMS)] and objective methods (Medication Refill Adherence (MRA) and HbA1c]. Results: Of 175 respondents, based on the three methods (MRA, ARMS, HbA1c), 13 respondents (7.4%) were adherent, namely one respondent (1.8%) in the insulin group and 12 respondents (10.1%) in the non-insulin group. Insulin administration affects adherence to antidiabetics by 0.123 times (95% CI: 0.015 - 1.024), or patients who use insulin have 87.7% lower adherence controlled by antidiabetic changes and the total number of medicines used. Conclusion: Insulin administration significantly affects medication adherence in diabetes mellitus patients with neurological complications.
Adikusuma, W. & Qiyaam, N. (2017). Hubungan Tingkat Kepatuhan Minum Obat Antidiabetik Oral Terhadap Kadar Hemoglobin Terglikasi (HbA1c) pada Pasien Diabetes Melitus Tipe 2. Jurnal Ilmiah Ibnu Sina; 2; 279–286.
Al AlShaikh, S., Quinn, T., Dunn, W., Walters, M. & Dawson, J. (2016). Predictive Factors of Non-Adherence to Secondary Preventative Medication After Stroke or Transient Ischaemic Attack: a Systematic Review and Meta-Analyses. European Stroke Journal; 1; 65–75. doi: 10.1177/2396987316647187.
Alfian, R. (2015). Korelasi Antara Kepatuhan Minum Obat dengan Kadar Gula Darah pada Pasien Diabetes Melitus Rawat Jalan dI RSUD DR. H. Moch. Ansari Saleh Banjarmasin. Jurnal Pharmascience; 2; 15–23.
Barati, M., Taheri-Kharameh, Z., Bandehelahi, K., Yeh, V. M. & Kripalani, S. (2018). Validation of the Short form of the Adherence to Refills and Medications Scale in Iranian Elders with Chronic Disease. Journal of Clinical and Diagnostic Research; 12; 10–13. doi: 10.7860/JCDR/2018/37584.12305.
Bauler, S., Jacquin-Courtois, S., Haesebaert, J., Luaute, J., Coudeyre, E., Feutrier, C., Allenet, B., Decullier, E., Rode, G. & Janoly-Dumenil, A. (2014). Barriers and Facilitators for Medication Adherence in Stroke Patients: A Qualitative Study Conducted in french Neurological Rehabilitation Units. European Neurology; 72; 262–270. doi: 10.1159/000362718.
Bloomgarden, Z. & Chilton, R. (2021). Diabetes and Stroke: an Important Complication. Journal of Diabetes; 13; 184–190. doi: 10.1111/1753-0407.13142.
Bulu, A., Wahyuni, T. D. & Sutriningsih, A. (2019). Hubungan antara Tingkat Kepatuhan Minum Obat dengan Kadar Gula Darah pada Pasien Diabetes Melitus Tipe II. Nursing News; 4; 181–189.
Capoccia, K., Odegard, P. S. & Letassy, N. (2016). Medication Adherence with Diabetes Medication: a Systematic Review of the Literature. The Diabetes Educator; 42; 34–71. doi: 10.1177/0145721715619038.
Chen, Y. J., Chang, J. & Yang, S. Y. (2020). Psychometric Evaluation of Chinese Version of Adherence to Refills and Medications Scale (ARMS) and Blood-Pressure Control Among Elderly with Hypertension. Patient Preference and Adherence; 14; 213–220. doi: 10.2147/PPA.S236268.
Complication Definition & Meaning. (2022). Merriam-Webster. (n.d.). https://www.merriam-webster.com/dictionary/complication#learn-more. Accessed: 15 July 2022.
Doggrell, S. A. & Warot, S. (2014). The Association Between the Measurement of Adherence to Antidiabetes Medicine and the HbA1c. International Journal of Clinical Pharmacy; 36; 488–497. doi: 10.1007/s11096-014-9929-6.
González-Bueno, J., Calvo-Cidoncha, E., Sevilla-Sánchez, D., Espaulella-Panicot, J., Codina-Jané, C. & Santos-Ramos, B. (2017). Spanish Translation and Cross-Cultural Adaptation of the ARMS-Scale for Measuring Medication Adherence in Polypathological Patients. Atencion Primaria; 49; 459–464. doi: 10.1016/j.aprim.2016.11.008.
International Diabetes Federation. (2019). IDF Diabetes Atlas (S. Karuranga, B. Malanda, P. Saeedi, & P. Salpea (Eds.); 9th ed.). Brussels: International Diabetes Federation.
Ireland, S., Endacott, R., Cameron, P., Fitzgerald, M. & Paul, E. (2010). Association of Glycaemia with Macrovascular and Microvascular Complications of Type 2 Diabetes: Prospective Observational Study. Resuscitation; 35; 18–23. doi: 10.1016/j.resuscitation.2010.10.016.
Jin, H. K., Kim, Y. H. & Rhie, S. J. (2016). Factors Affecting Medication Adherence in Elderly People. Patient Preference and Adherence; 10; 2117–2125. https://doi.org/10.2147/PPA.S118121
Kim, C.-J., Park, E., Schlenk, E. A., Kim, M. & Kim, D. J. (2016). Psychometric Evaluation of a Korean Version of the Adherence to Refills and Medications Scale (ARMS) in Adults With Type 2 Diabetes. Diabetes Educator; 42; 188–198. doi: 10.1177/0145721716632062.
Kim, H. -A., Shin, J. -Y., Kim, M. -H. & Park, B. -J. (2014). Prevalence and Predictors of Polypharmacy among Korean elderly. PLoS ONE; 9; 1-7. doi: 10.1371/journal.pone.0098043.
Kindmalm, L., Melander, A. & Nilsson, L. (2007). Refill Adherence of Antihyperglycaemic Drugs Related to Glucose Control (HbA 1c) in Patients with Type 2 Diabetes. Acta Diabetologica; 44; 209–213. doi: 10.1007/s00592-007-0006-7.
Kripalani, S., Risser, J., Gatti, M. E. & Jacobson, T. A. (2009). Development and Evaluation of the Adherence to Refills and Medications Scale (ARMS) Among Low-Literacy Patients with Chronic Disease. Value in Health; 12; 118–123. doi: 10.1111/j.1524-4733.2008.00400.x.
Lachenbruch, P. A., Lwanga, S. K. & Lemeshow, S. (1991). Sample Size Determination in Health Studies: A Practical Manual. Journal of the American Statistical Association; 86; 1149. doi: 10.2307/2290547.
Lomper, K., Chabowski, M., Chudiak, A., BiaÅ‚oszewski, A., Dudek, K. & Jankowska-PolaÅ„ska, B. (2018). Psychometric Evaluation of the Polish Version of the Adherence to Refills and Medications Scale (ARMS) in Adults with Hypertension. Patient Preference and Adherence; 12; 2661–2670. doi: 10.2147/PPA.S185305.
Nanda, O. D., Wiryanto, B. & Triyono, E. A. (2018). Hubungan Kepatuhan Minum Obat Antidiabetik dengan Regulasi Kadar Gula Darah pada Pasien Perempuan Diabetes Mellitus. Amerta Nutrition; 2; 340-348. doi: 10.20473/amnt.v2i4.2018.340-348.
Osborn, C. Y. & Gonzalez, J. S. (2016). Measuring Insulin Adherence Among Adults with Type 2 Diabetes. Journal of Behavioral Medicine; 39; 633–641. doi: 10.1007/s10865-016-9741-y.
Park, H. Y., Seo, S. A., Yoo, H. & Lee, K. (2018). Medication Adherence and Beliefs About Medication in Elderly Patients Living Alone with Chronic Diseases. Patient Preference and Adherence; 12; 175–181. doi: 10.2147/PPA.S151263.
Perkeni. (2021). Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 di Indonesia. Jakarta: Perkeni.
Saadat, Z., Nikdoust, F., Aerab-Sheibani, H., Bahremand, M., Shobeiri, E., Saadat, H., Moharramzad, Y. & Morisky, D. E. (2015). Adherence to Antihypertensives in Patients with Comorbid Condition. Nephro-Urology Monthly; 7; 1-6. doi: 10.5812/numonthly.29863.
Salistyaningsih, W., Puspitawati, T. & Nugroho, D. (2011). Hubungan Tingkat Kepatuhan Minum Obat Hipoglikemik Oral dengan Kadar Glukosa Darah Pada Pasien DM Tipe 2. Universitas Respati Yogyakarta; 27; 215–221.
Sarwar, N., Gao, P., Kondapally Seshasai, S. R., Gobin, R., Kaptoge, S., Di Angelantonio, E., Ingelsson, E., Lawlor, D. A., Selvin, E., Stampfer, M., Stehouwer, C. D. A., Lewington, S., Pennells, L., Thompson, A., Sattar, N., White, I. R., Ray, K. K., Danesh, J., Tipping, R. W. & Wormser, D. (2010). Diabetes Mellitus, Fasting Blood Glucose Concentration, and Risk of Vascular Disease: A Collaborative Meta-Analysis of 102 Prospective Studies. The Lancet; 375; 2215–2222. doi: 10.1016/S0140-6736(10)60484-9.
Shams, N., Amjad, S., Kumar, N., Ahmed, W. & Saleem, F. (2016). Drug Non-Adherence In Type 2 Diabetes Mellitus; Predictors and Associations. Journal of Ayub Medical College, Abbottabad; 28; 302–307.
Sherwani, S. I., Khan, H. A., Ekhzaimy, A., Masood, A. & Sakharkar, M. K. (2016). Significance of HbA1c Test in Diagnosis and Prognosis of Diabetic Patients. Biomarker Insights; 11; 95–104. doi: 10.4137/Bmi.s38440.
Shou, J., Zhou, L., Zhu, S. & Zhang, X. (2015). Diabetes is an Independent Risk Factor for Stroke Recurrence in Stroke Patients: A Meta-analysis. Journal of Stroke and Cerebrovascular Diseases; 24; 1961–1968. doi: 10.1016/j.jstrokecerebrovasdis.2015.04.004.
WHO. (2020). The Top 10 Causes of Death. Geneva: WHO.
Zairina, E., Khotib, J., Ardianto, C. & Sulaiman, S. A. (2018). Unity in Diversity and the Standardisation of Clinical Pharmacy Services. Florida: CRC Press.
Zairina, E., Nugraheni, G., Sulistyarini, A., Mufarrihah, Setiawan, C. D., Kripalani, S. & Lestari, S. I. (2022). Factors Related to Barriers and Medication Adherence in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study. Journal of Diabetes and Metabolic Disorders; 21; 219–228. doi: 10.1007/s40200-021-00961-6.
Zhang, Z. P., Premikha, M., Luo, M. & Venkataraman, K. (2021). Diabetes Distress and Peripheral Neuropathy are Associated with Medication Non-Adherence in Individuals with Type 2 Diabetes in Primary Care. Acta Diabetologica; 58; 309–317. doi: 10.1007/s00592-020-01609-2.
Copyright (c) 2022 JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
1. The copyright of this journal belongs to the Editorial Board and Journal Manager with the author's knowledge, while the moral right of the publication belong to the author.
2. The formal legal aspect of journal publication accessibility refers to the Creative Commons Attribution-Non-Commercial-Share Alike (CC BY-NC-SA), which implies that the publication can be used for non-commercial purposes in its original form.
3. Every publication (print/electronic) is open access for educational, research, and library purposes. In addition to the objectives mentioned above, the editorial board is not responsible for copyright infringement
.jpg)
